828
Articles
18.9K
Citations
2.3
avg. Impact Factor
68
h-index

Most Cited Articles of Department of Urology in 2005

TitleJournalYearCitations
A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trialEuropean Urology2005257
Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinomaJournal of Clinical Oncology2005249
The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysisEuropean Urology2005182
The role of urinary urgency and its measurement in the overactive bladder symptom syndrome: current concepts and future prospectsBJU International2005176
A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladderBJU International2005116
The expression and regulation of ADAMTS-1, -4, -5, -9, and -15, and TIMP-3 by TGFbeta1 in prostate cells: relevance to the accumulation of versicanProstate200580
Prognostic value of serum markers for prostate cancerScandinavian Journal of Urology and Nephrology200555
An open, multicentre study of NASHA/Dx Gel (Zuidex) for the treatment of stress urinary incontinenceEuropean Urology200550
Recent advances in basic science for overactive bladderCurrent Opinion in Urology200546
Stress incontinence injection therapy: what is best for our patients?European Urology200541
Comparison of darifenacin and oxybutynin in patients with overactive bladder: assessment of ambulatory urodynamics and impact on salivary flowEuropean Urology200535
Vesico-vaginal fistulaBJU International200532
A critical review of diagnostic criteria for evaluating patients with symptomatic stress urinary incontinenceBJU International200517
Primer: questionnaires versus urodynamics in the evaluation of lower urinary tract dysfunction-one, both or none?Nature Reviews Urology200517
The urgency of the problem and the problem of urgency in the overactive bladderBJU International200514
Towards a better understanding of involuntary detrusor activityBJU International200514
The Development of the Oral Controlled Absorption System (OCAS®): A New Improved Formulation of TamsulosinEuropean Urology Supplements20057
Night Time Symptom Control with Omnic (Tamsulosin) Oral Controlled Absorption System (OCAS®)European Urology Supplements20057
An evaluation of a telephone follow-up clinic in urologyJournal of Sexual Medicine20055
The Road to Cystectomy: Who, When and Why?EAU Update Series20054
The Oral Controlled Absorption System (OCAS®): The Evolution of Tamsulosin for the Treatment of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH)European Urology Supplements20051